BioCryst Pharmaceuticals (BCRX, $7.25) Moving Average Convergence Divergence (MACD) Histogram turned negative on April 1, 2025

#Biotechnology, #TechnicalAnalysis, #MACD, #Bearish, #Stocks, #SmallCap, #Russel2000
BCRX - BioCryst Pharmaceuticals
MACD signal
Bearish Trend
72%
Odds of DOWN Trend
Price: $7.25
Daily change: -$0.25 (-3.33%)
Daily volume: 2.2M
Capitalization: $1.5B
Industry: Biotechnology

This is a Bearish indicator signaling BCRX's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 60 similar cases where BCRX's MACD histogram became negative, and 43 of them led to successful outcomes. Odds of Success: 72%.